l-carnitine cardiac function | Linus Pauling Institute Safety and efficacy of L-carnitine
Description
Biodisponibilitatea carnitinei din suplimentele alimentare este mult mai sczut , de aproximativ 14-18%
PCSK9 inhibition for dyslipidemia in cancer A 1996 study first reported an increased risk of metabolic syndrome, including dyslipidemia, in long-term survivors of childhood cancer (Talvensaari et al., 1996)
Because ZnC contains zinc, very large amounts could theoretically cause zinc imbalance (though standard doses are safe)
.
